MOCON, Inc. (NASDAQ:MOCO), today reported financial results for the
first quarter ended March 31, 2017.
First Quarter 2017 Revenue and Earnings
Summary
First quarter 2017 results compared to first
quarter 2016:
- Revenue increased five percent. The euro declined by three
percent year-over-year which negatively impacted our overall growth
rate by two percentage points.
- Revenue from foreign customers accounted for 66 percent for
2017 compared to 68 percent in 2016
- Operating income was $0.8 million, or five percent of revenue
for both 2017 and 2016
- Net loss was $27,000, or $0.00 per share, compared to a net
income of $0.5 million, or $0.08 per diluted share
- Adjusted EBITDA was $1.7 million, or 11 percent of revenue,
compared to $1.6 million, or 11 percent of revenue (See
reconciliation to non-GAAP information below)
Revenue and Gross Margin by Segment ($ in
thousands)
|
|
Three Months Ended March 31, |
|
|
|
Revenue |
|
|
Gross Margin as a % of
Revenue |
|
|
|
|
2017 |
|
|
2016 |
|
Growth % |
|
|
2017 |
|
2016 |
|
Package Testing |
|
$ |
7,436 |
|
$ |
7,002 |
|
6 |
% |
|
|
59 |
% |
|
58 |
% |
|
Permeation |
|
|
5,583 |
|
|
5,283 |
|
6 |
% |
|
|
58 |
% |
|
57 |
% |
|
Industrial Analyzers and Other |
|
2,477 |
|
|
2,445 |
|
1 |
% |
|
|
43 |
% |
|
44 |
% |
|
Total Revenue |
|
$ |
15,496 |
|
$ |
14,730 |
|
5 |
% |
|
|
56 |
% |
|
55 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from the Package Testing segment for the first quarter
ended March 31, 2017 increased 6 percent due primarily to continued
growth in demand for our products in the US and Europe. The euro
declined by three percent year-over-year which negatively impacted
our Pakage Testing segment’s growth rate by three percentage
points.
Revenue for the Permeation segment for the first
quarter ended March 31, 2017 increased by 6 percent compared to the
year-ago quarter. The Permeation segment growth is
attributable to an increase in domestic sales for instruments. The
year-over-year euro decline mentioned above negatively impacted our
Permeation segment’s growth rate by one percentage point.
The Industrial Analyzers and Other segment
increased by one percent for the first quarter ended March 31, 2017
compared to the year-ago quarter. The increase was driven by an
increase in BevAlert instruments and sensors which was offset by a
decrease in microbial detection products.
Gross Profit, Operating Income and
Operating Expense Commentary
For the three-months ended March 31, 2017 gross
profit was 56 percent up from 55 percent of revenue in the same
period in 2016, driven by volume based efficiencies realized in our
Permeation and Package Testing segments.
Selling, general and administrative expenses were
$6.5 million, or 42 percent of revenue, for the first quarter ended
March 31, 2017 compared to $6.1 million, or 42 percent of revenue,
in the year-ago quarter. We incurred approximately $0.3
million in expenses during the first quarter of 2017 related to the
recently announced merger agreement with AMETEK. Research and
development expenses were nine percent of revenue in the first
quarter 2017, compared to eight percent in the year-ago quarter
which is higher than our targeted spending targets of 6 to 8
percent of revenue and was driven by product development for OEM
products.
Overall, operating income was five percent of
revenue in both of the first quarters ended March 31, 2017 and
2016.
Income Tax Expense and Net Loss
Commentary
Tax expense was 103 percent of income before income
taxes, or $0.8 million, for the first quarter ended March 31, 2017
compared to 33 percent, or $0.2 million, for the first quarter
ended March 31, 2017. The increase in the effective tax rate
is due to discrete events occurring during the three months ended
March 31, 2017 related to the transaction costs incurred and
additional reserves for uncertain tax positions. Net loss was
$27,000, or $0.00 per fully diluted share, in the first
quarter of 2017 and net income was $0.5 million, or $0.08 per
diluted share, in the first quarter of 2016.
Balance Sheet and Cash Flow
Summary
- Cash and cash equivalents increased to $11.2 million at March
31, 2016 compared to $8.3 million at December 31, 2016.
- Days sales outstanding were 61 in the first quarter of 2017
compared to 57 in the fourth quarter of 2016.
- Total debt was $1.3 million at March 31, 2017 compared to $0.2
million at and December 31, 2016.
About MOCON
MOCON is a leading provider of detectors,
instruments, systems and consulting services to research
laboratories, production facilities, and quality control and safety
departments in the medical, pharmaceutical, food and beverage,
packaging, environmental, oil and gas and other industries
worldwide. See www.mocon.com for more information.
Use of Non-GAAP Financial
Measures
MOCON supplements its financial statements to
provide investors with earnings before interest, taxes,
depreciation and amortization (“EBITDA”) and EBITDA plus
share-based compensation, gain on sale of business, realignment
expenses, and foreign currency transactional losses (“Adjusted
EBITDA”), which are not calculated in accordance with general
accepted accounting principles (“GAAP”) in the United States of
America.
MOCON believes that these non-GAAP measures provide
useful information to the company’s Board of Directors, management
and investors regarding certain trends relating to its financial
condition and operating performance. MOCON’s management uses these
non-GAAP measures to compare the company's performance to that of
prior periods for trend analyses and planning purposes
The method MOCON uses to produce non-GAAP results
is not computed according to GAAP, is likely to differ from the
methods used by other companies and should not be regarded as a
replacement for corresponding GAAP measures. MOCON urges investors
to review the reconciliation of its non-GAAP financial measures to
the comparable GAAP financial measures that are included in this
press release.
Safe Harbor
This press release contains forward-looking
statements that are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include statements that can be
identified by words such as “will,” “may,” “expect,” “believe,”
“anticipate,” “estimate,” “continue,” “planned”, or other similar
expressions. All forward-looking statements speak only as of
the date of this press release. MOCON undertakes no
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events or
otherwise. In addition to the risks and uncertainties of
ordinary business operations and conditions in the general economy
and the markets in which the company competes, there are important
factors that could cause actual results to differ materially from
those anticipated by the forward-looking statements made in this
press release. These factors include, but are not limited to,
impact of MOCON’s pending merger with AMETEK, including
uncertainties as to if or when the closing of the merger may occur
and the effects of disruption from the announcement of the entry
into the merger agreement; MOCON’s ability to realize the cost
savings associated with the realignment plan that was begun in
2015, fluctuations in foreign currency exchange rates, the terms of
MOCON’s credit agreement including financial covenants included
therein, dependence on certain key industries, pricing and
lack of availability of raw materials, crude oil pricing impact on
oil exploration activities, and other factors set forth in the
company’s Annual Report on Form 10-K for the year ended
December 31, 2016 and other documents MOCON files with or
furnishes to the Securities and Exchange Commission.
MOCON's shares are traded on the NASDAQ
Global Market System under the symbol MOCO.MOCON is a
registered trademark of MOCON, Inc.; other trademarks are those of
their respective holders.
MOCON, INC. |
SUMMARY CONSOLIDATED FINANCIAL
DATA |
(in Thousands, Except Per Share
Data) |
|
|
|
|
STATEMENT OF OPERATIONS
DATA: (unaudited) |
|
|
|
|
Quarters Ended March 31, |
|
|
2017 |
|
|
|
2016 |
|
Revenue |
|
|
|
Products |
$ |
12,345 |
|
|
$ |
11,384 |
|
Services |
|
2,726 |
|
|
|
2,812 |
|
Consulting |
|
425 |
|
|
|
534 |
|
Total revenue |
|
15,496 |
|
|
|
14,730 |
|
Cost of
revenue |
|
|
|
Products |
|
5,272 |
|
|
|
4,970 |
|
Services |
|
1,137 |
|
|
|
1,174 |
|
Consulting |
|
423 |
|
|
|
482 |
|
Total cost of revenue |
|
6,832 |
|
|
|
6,626 |
|
Gross profit |
|
8,664 |
|
|
|
8,104 |
|
|
|
|
|
Selling,
general and administrative expenses |
|
6,488 |
|
|
|
6,138 |
|
Research and
development expenses |
|
1,358 |
|
|
|
1,203 |
|
Operating income |
|
818 |
|
|
|
763 |
|
Other expense,
net |
|
(40 |
) |
|
|
(35 |
) |
Income before income taxes |
|
778 |
|
|
|
728 |
|
Income tax
expense |
|
805 |
|
|
|
240 |
|
Net income (loss) |
$ |
(27 |
) |
|
$ |
488 |
|
Net income
(loss) per common share: |
|
|
|
Basic |
$ |
- |
|
|
$ |
0.08 |
|
Diluted |
$ |
- |
|
|
$ |
0.08 |
|
Weighted
average common shares outstanding: |
|
|
|
Basic |
|
5,856 |
|
|
|
5,797 |
|
Diluted |
|
5,856 |
|
|
|
5,816 |
|
|
|
|
|
|
|
|
|
|
CONDENSED
BALANCE SHEET DATA: (unaudited) |
|
|
|
|
|
March 31, 2017 |
|
December 31, 2016 |
|
Assets: |
|
|
|
|
Cash and marketable securities |
$ |
11,162 |
|
$ |
8,313 |
|
Accounts receivable, net |
|
10,443 |
|
|
10,726 |
|
Inventories |
|
7,515 |
|
|
6,728 |
|
Other current assets |
|
1,788 |
|
|
1,395 |
|
Total current assets |
|
30,908 |
|
|
27,162 |
|
Property, plant and equipment, net |
|
5,394 |
|
|
5,457 |
|
Goodwill, intangibles and other assets |
|
15,412 |
|
|
15,829 |
|
Total assets |
$ |
51,714 |
|
$ |
48,448 |
|
Liabilities and
Shareholders’ Equity: |
|
|
|
|
Notes payable, current |
$ |
82 |
|
$ |
83 |
|
Other current liabilities |
|
13,013 |
|
|
10,632 |
|
Total noncurrent liabilities |
|
2,421 |
|
|
1,282 |
|
Shareholders’ equity |
|
36,198 |
|
|
36,451 |
|
Total liabilities and shareholders’
equity |
$ |
51,714 |
|
$ |
48,448 |
|
|
|
|
|
|
CONDENSED CASH
FLOW DATA: (unaudited) |
March 31, 2017 |
|
March 31, 2016 |
|
|
|
|
Net cash
provided by operations |
$ |
3,056 |
|
|
$ |
93 |
|
Net cash used
in investing activities |
|
(186 |
) |
|
|
(102 |
) |
Net cash
provided by (used in) financing activities |
|
695 |
|
|
|
(578 |
) |
Effect of
exchange rate changes |
|
(716 |
) |
|
|
205 |
|
Net increase
(decrease) in cash |
|
2,849 |
|
|
|
(382 |
) |
Cash beginning
of period |
|
8,313 |
|
|
|
6,344 |
|
Cash end of
period |
$ |
11,162 |
|
|
$ |
5,962 |
|
|
|
|
|
MOCON, INC. |
|
NON-GAAP RECONCILIATION |
|
(in Thousands) |
|
|
|
|
|
|
|
Quarter Ended March 31, |
|
|
|
2017 |
|
|
|
2016 |
|
|
|
|
|
|
|
Net income
(loss) |
$ |
(27 |
) |
|
$ |
488 |
|
|
Interest expense, net |
|
- |
|
|
|
26 |
|
|
Income tax expense |
|
805 |
|
|
|
240 |
|
|
Depreciation and amortization |
|
668 |
|
|
|
689 |
|
|
|
|
|
|
|
EBITDA |
|
1,446 |
|
|
|
1,443 |
|
|
Share-based compensation |
|
205 |
|
|
|
186 |
|
|
Foreign currency transaction loss |
|
37 |
|
|
|
9 |
|
|
|
|
|
|
|
Adjusted EBITDA |
$ |
1,688 |
|
|
$ |
1,638 |
|
|
|
|
|
|
|
MOCON, Inc. Company Contacts:
Elissa Lindsoe, CFO
763-493-6370 / www.mocon.com
Or
Steven Hooser, Investor Relations
Three Part Advisors, LLC
(214) 872-2710
Mocon (NASDAQ:MOCO)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Mocon (NASDAQ:MOCO)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025